Inventor · disambiguated record
Lawrence Irwin Glass
Also filed as: GLASS LAWRENCE IRWIN
5 granted patents·4 pending applications·11 citations·filing 2015–2025
72Inventor score
Top patents by PatentIndex Score
9 records- 0186US9212204B2Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acidNEUREN PHARMACEUTICALS LTD·Filed 2015·Granted Dec 15, 2015·8 cites·7 claims
- 0277US9867823B2Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disordersNEUREN PHARMACEUTICALS LTD·Filed 2016·Granted Jan 16, 2018·3 cites·19 claims
- 0361US11197856B2Bicyclic compounds and methods for their use in treating autismNEUREN PHARMACEUTICALS LTD·Filed 2020·Granted Dec 14, 2021·0 cites·24 claims
- 0461US2025367192A1Bicyclic compounds and methods for their use in treating pitt hopkins syndromeNEUREN PHARMACEUTICALS LTD·Filed 2025·Application pending·0 cites
- 0556US10548892B2Bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disordersNEUREN PHARMACEUTICALS LTD·Filed 2018·Granted Feb 4, 2020·0 cites·30 claims
- 0649US2024132511A1Treatments of prader-willi syndromeNEUREN PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 0748US12472177B2Bicyclic compounds and methods for their use in treating Pitt Hopkins syndromeNEUREN PHARMACEUTICALS LTD·Filed 2020·Granted Nov 18, 2025·0 cites·18 claims
- 0847US2022339138A1Methods and compositions for treatment of rett syndromeACADIA PHARM INC·Filed 2022·Application pending·0 cites
- 0935US2015224164A1Treatment of autism spectrum disorders using glycyl-l-2-methylprolyl-l-glumatic acidNEUREN PHARMACEUTICALS LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lawrence Irwin Glass files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →